GlassScriptPhysician profile
Jason Shoe
NPI 1497020275
$2,238.68
in general payments reported to CMS, 2019-2025
12 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $78.59 · 2021: $195 · 2022: $431 · 2023: $639 · 2024: $334 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightforce Orthodontics, INC. | $775.46 | 2022-2025 | |
| 3m Company | $568.34 | 2019-2023 | Clarity Aligners, Transbond Idb |
| Align Technology, INC. | $189.78 | 2019-2025 | Invisalign |
| World Class Technology Corporation | $171.57 | 2023 | Pitts21, Pitts21 Pro |
| Envista Holdings Corporation | $143.31 | 2024-2025 | Damon, Titanium Orthos, Spark |
| USA Angelalign Technology Corp | $116.23 | 2023-2025 | |
| Gc America INC. | $96.40 | 2019-2024 | Legend, Chic, Mipaste Plus Strawberry |
| Solventum Corporation | $70.71 | 2024 | Clarity Aligners |
| Ormco Corporation | $33.35 | 2023 | Spark |
| Nobel Biocare USA | $33.35 | 2023 | Nobelactive |
| Dentsply Sirona INC | $25.18 | 2020 | |
| American Orthodontics Corporation | $15.00 | 2024 | Master Series, LP and Ifit Tubes, Radiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$750,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Shoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.